The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis

Clinical trial NCT01711164 · COMPLETED

Trial details

NCT number: NCT01711164
Sponsor: University Health Network, Toronto
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C Infection

Start date: 2014-01-01
Primary completion: 2016-05-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.